Internal Medicine, Endocrinology, Diabetes, & Metabolism · Saint Louis, MO
NPI
1720078843
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
12900 Tesson Ferry Rd Ste 101
Saint Louis, MO, 63128
Phone (314) 843-4848
Groups this clinician bills Medicare through
Medicare paid, 2024
$173K
3,251 services
Medicare patients, 2024
516
Average age 72
Drug cost, 2024
$5.0M
10,163 prescriptions
Company payments, 2025
$1,763
From 33 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bharathi Raju was code J0897 (injection, denosumab, 1 mg), 1,260 times for 21 patients. In total Bharathi Raju billed 3,251 services in 21 codes, and Medicare paid $173K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,260 | 21 | $19.15 | $24K |
| 99214 Office E&M - Established | Office | 675 | 272 | $93.35 | $63K |
| 95251 Test - Miscellaneous | Office | 376 | 157 | $26.15 | $9,832 |
| 99232 Hospital E&M - Subsequent | Facility | 277 | 67 | $63.91 | $18K |
| 99213 Office E&M - Established | Office | 145 | 101 | $61.25 | $8,882 |
| 99233 Hospital E&M - Subsequent | Facility | 122 | 81 | $96.14 | $12K |
| 99223 Hospital E&M - Initial | Facility | 110 | 100 | $137.97 | $15K |
| G0108 Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 69 | 23 | $44.19 | $3,049 |
| 99205 Office E&M - New | Office | 40 | 40 | $149.96 | $5,998 |
| 99231 Hospital E&M - Subsequent | Facility | 33 | 14 | $40.25 | $1,328 |
| 99222 Hospital E&M - Initial | Facility | 23 | 23 | $105.84 | $2,434 |
| 96372 Injection Administration | Office | 23 | 22 | $11.01 | $253 |
| 99309 SNF E&M | Office | 22 | 11 | $87.05 | $1,915 |
| 99204 Office E&M - New | Office | 22 | 22 | $123.62 | $2,720 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 19 | 13 | $48.30 | $918 |
By year: 2022 $208K for 4,834 services; 2023 $195K for 4,560 services; 2024 $173K for 3,251 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bharathi Raju prescribed most often to Medicare patients was Levothyroxine Sodium, with 596 prescriptions and refills. In total Bharathi Raju wrote 10,163 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 596 | 1,421 | 164 | $5,659 |
| Metformin Hcl Er Metformin Hcl | 564 | 1,528 | 199 | $6,571 |
| Atorvastatin Calcium Generic | 496 | 1,304 | 158 | $5,607 |
| Ozempic Semaglutide | 495 | 968 | 135 | $938K |
| Jardiance Empagliflozin | 475 | 895 | 118 | $506K |
| Rosuvastatin Calcium Generic | 316 | 872 | 93 | $3,805 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 277 | 667 | 97 | $52K |
| Mounjaro Tirzepatide | 265 | 394 | 60 | $417K |
| Glimepiride Generic | 253 | 636 | 87 | $1,912 |
| Metformin Hcl Generic | 242 | 680 | 76 | $2,638 |
| Pioglitazone Hcl Generic | 239 | 546 | 71 | $2,899 |
| Trulicity Dulaglutide | 222 | 306 | 53 | $300K |
| Novolog Flexpen Insulin Aspart | 204 | 397 | 74 | $89K |
| Methimazole Generic | 193 | 455 | 55 | $1,898 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 185 | 492 | 82 | $30K |
Brand drugs: 4,570 claims; generic drugs: 4,768 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bharathi Raju $1,763 ($1,763 in general payments such as food, travel and fees) from 33 companies. The largest payer was Novo Nordisk Inc with $187.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 11 | $187 |
| Lilly USA, LLC LLY | 15 | $173 |
| Madrigal Pharmaceuticals MDGL | 5 | $104 |
| Amgen Inc. AMGN | 5 | $90.14 |
| Sanofi-Aventis U.S. LLC SNY | 3 | $89.09 |
| Xeris Pharmaceuticals, Inc. | 4 | $84.13 |
| Verity Pharmaceuticals Inc. | 1 | $69.31 |
| Corcept Therapeutics CORT | 3 | $63.46 |
| Abbott Laboratories ABT | 3 | $58.1 |
| Globus Medical, Inc. GMED | 1 | $57.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.